CD8A and neoplasm: Higher densities of CD8+ T cells in the tumor microenvironment were the best predictor of improved survival.[4] Taken together with our proinflammatory cytokine data, these observations support the testing of baseline and /or early-on treatment biomarkers of the pro-inflammatory immune response in both tumor tissue and in circulating blood and evaluated simultaneously due to the common systems biology.